Biofrontera (BFRI) Share-based Compensation (2021 - 2026)
Biofrontera (BFRI) posted quarterly Share-based Compensation of $289000.0 for Q4 2025, down 70.87% year-over-year from $992000.0 in Q4 2024, and up 189.0% quarter-over-quarter from $100000.0 in Q3 2025.
Biofrontera (BFRI) Share-based Compensation (2021 - 2026) Analysis & Trends
Biofrontera's Share-based Compensation history runs 5 years deep, the most recent figure standing at $289000.0 for Q4 2025.
- In Q4 2025, Share-based Compensation fell 70.87% year-over-year to $289000.0; the TTM figure through Dec 2025 stood at $1.5 million (down 2.57% YoY), while the FY2025 annual figure was $951000.0, down 6.67% from the prior year.
- Share-based Compensation for Q4 2025 stood at $289000.0, up from $100000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $2.7 million in Q2 2022, with the low at -$17000.0 in Q4 2023.
- The 5-year median for Share-based Compensation is $228000.0 (2024), against an average of $463058.8.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 104.44% in 2023, then soared 5935.29% in 2024.
- Biofrontera's Share-based Compensation stood at $129000.0 in 2021, then jumped by 196.9% to $383000.0 in 2022, then tumbled by 104.44% to -$17000.0 in 2023, then jumped by 5935.29% to $992000.0 in 2024, then tumbled by 70.87% to $289000.0 in 2025.
- Business Quant data shows BFRI's Share-based Compensation at $289000.0 in Q4 2025, $100000.0 in Q3 2025, and $700000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Jun 30, 2026 | 800,000.00 |
| Dec 31, 2025 | 289,000.00 |
| Dec 31, 2025 | 289,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 992,000.00 |
| Dec 31, 2024 | 992,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Dec 31, 2023 | -17,000.00 |
| Dec 31, 2023 | -17,000.00 |